Barnett & Company Inc. decreased its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 2.3% during the third quarter, Holdings Channel reports. The institutional investor owned 2,205 shares of the pharmacy operator’s stock after selling 53 shares during the period. Barnett & Company Inc.’s holdings in Walgreens Boots Alliance were worth $178,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently modified their holdings of the company. Hudock Capital Group LLC increased its position in Walgreens Boots Alliance by 0.4% in the third quarter. Hudock Capital Group LLC now owns 1,641 shares of the pharmacy operator’s stock valued at $132,000 after buying an additional 7 shares during the period. Zacks Investment Management increased its position in Walgreens Boots Alliance by 0.3% in the third quarter. Zacks Investment Management now owns 3,979 shares of the pharmacy operator’s stock worth $321,000 after buying an additional 11 shares in the last quarter. Alpha Windward LLC increased its position in Walgreens Boots Alliance by 0.6% in the third quarter. Alpha Windward LLC now owns 3,227 shares of the pharmacy operator’s stock worth $260,000 after buying an additional 18 shares in the last quarter. Thomaspartners Inc. increased its position in Walgreens Boots Alliance by 0.5% in the third quarter. Thomaspartners Inc. now owns 4,357 shares of the pharmacy operator’s stock worth $351,000 after buying an additional 20 shares in the last quarter. Finally, First Citizens Bank & Trust Co. increased its position in Walgreens Boots Alliance by 0.9% in the second quarter. First Citizens Bank & Trust Co. now owns 2,470 shares of the pharmacy operator’s stock worth $206,000 after buying an additional 21 shares in the last quarter. Hedge funds and other institutional investors own 59.98% of the company’s stock.
Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at 83.79 on Wednesday. The stock has a 50 day moving average price of $82.56 and a 200-day moving average price of $82.24. Walgreens Boots Alliance Inc has a one year low of $75.74 and a one year high of $88.00. The company has a market capitalization of $90.44 billion, a P/E ratio of 22.17 and a beta of 1.20.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, January 5th. The pharmacy operator reported $1.10 EPS for the quarter, beating the Zacks’ consensus estimate of $1.09 by $0.01. The business had revenue of $28.50 billion for the quarter. Walgreens Boots Alliance had a return on equity of 16.76% and a net margin of 3.52%. The business’s revenue was down 1.8% on a year-over-year basis. During the same period in the prior year, the company posted $1.03 EPS. Equities research analysts predict that Walgreens Boots Alliance Inc will post $5.00 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 10th. Stockholders of record on Wednesday, February 15th will be issued a dividend of $0.375 per share. This represents a $1.50 dividend on an annualized basis and a dividend yield of 1.79%. The ex-dividend date of this dividend is Monday, February 13th. Walgreens Boots Alliance’s dividend payout ratio is 39.68%.
This article was originally posted by sleekmoney and is the sole property of of sleekmoney. If you are accessing this article on another website, it was illegally stolen and republished in violation of U.S. and international copyright legislation. The legal version of this article can be read at http://sleekmoney.com/barnett-company-inc-lowers-stake-in-walgreens-boots-alliance-inc-wba/1661977.html.
WBA has been the subject of several research analyst reports. Atlantic Securities raised shares of Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and set a $95.00 price target for the company in a research report on Monday, February 6th. Deutsche Bank AG restated a “buy” rating and set a $92.00 price objective on shares of Walgreens Boots Alliance in a report on Tuesday, January 31st. Evercore ISI reaffirmed a “buy” rating and issued a $93.00 target price on shares of Walgreens Boots Alliance in a research report on Tuesday, January 31st. Wells Fargo & Company reiterated an “outperform” rating on shares of Walgreens Boots Alliance in a report on Tuesday, January 31st. Finally, Zacks Investment Research downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Tuesday, January 31st. One analyst has rated the stock with a sell rating, four have assigned a hold rating and twelve have given a buy rating to the company. Walgreens Boots Alliance currently has an average rating of “Buy” and a consensus target price of $91.38.
In related news, Director Janice M. Babiak acquired 600 shares of the stock in a transaction dated Thursday, February 2nd. The shares were acquired at an average price of $80.68 per share, with a total value of $48,408.00. Following the acquisition, the director now owns 600 shares in the company, valued at approximately $48,408. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Ornella Barra acquired 124,000 shares of the stock in a transaction dated Tuesday, February 7th. The shares were bought at an average cost of $80.93 per share, for a total transaction of $10,035,320.00. Following the acquisition, the chief operating officer now owns 1,690,336 shares in the company, valued at approximately $136,798,892.48. The disclosure for this purchase can be found here. Corporate insiders own 13.50% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/barnett-company-inc-lowers-stake-in-walgreens-boots-alliance-inc-wba/1661977.html
Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with MarketBeat.com's FREE daily email newsletter.